• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧和 MITF 调节黑素细胞中的 KIT 致癌特性。

Hypoxia and MITF regulate KIT oncogenic properties in melanocytes.

机构信息

INSERM, U976, Centre de Recherche sur la Peau, Hôpital Saint-Louis, Paris, France.

Université Paris Diderot, Sorbonne Paris Cité, UMRS976, Paris, France.

出版信息

Oncogene. 2016 Sep 22;35(38):5070-7. doi: 10.1038/onc.2016.39. Epub 2016 Mar 14.

DOI:10.1038/onc.2016.39
PMID:26973244
Abstract

KIT mutations are frequent in acral, mucosal and chronic sun-damage (CSD) melanoma, but little is known about the mechanisms driving the transformation of KIT-mutated melanocytes into melanoma cells. We showed that exposition of melanocytes harboring the (L576P)KIT mutation to a hypoxic environment induced their transformation into malignant cells. Transformed (L576P)KIT melanocytes showed downregulation of MITF expression characteristic of melanoma initiating cells (MICs). In agreement, these cells were able to form spheres in neural crest cell medium and low-adherence conditions, also a characteristic of MICs. Downregulation of MITF by RNA interference induced transformation of KIT-mutated melanocytes in normoxia and acquisition of a MIC phenotype by these cells. Hence, low level of MITF cooperates with oncogenic KIT to transform melanocytes. Activation of the cAMP pathway in transformed (L576P)KIT melanocytes stimulated MITF expression, and reduced cellular proliferation and sphere formation. These findings highlight the essential role of MITF in revealing the oncogenic activity of KIT in melanocytes and suggest that the cAMP pathway is a therapeutic target in KIT-mutated melanoma.

摘要

KIT 突变在肢端、黏膜和慢性日光损伤(CSD)黑素瘤中很常见,但对于驱动 KIT 突变的黑素细胞转化为黑素瘤细胞的机制知之甚少。我们表明,将携带(L576P)KIT 突变的黑素细胞暴露于低氧环境中会诱导其转化为恶性细胞。转化的(L576P)KIT 黑素细胞表现出 MITF 表达下调的特征,这是黑素瘤起始细胞(MICs)的特征。与此一致,这些细胞能够在神经嵴细胞培养基和低黏附条件下形成球体,这也是 MICs 的特征。MITF 的 RNA 干扰下调诱导 KIT 突变黑素细胞在常氧条件下转化,并使这些细胞获得 MIC 表型。因此,MITF 的低水平与致癌性 KIT 共同作用来转化黑素细胞。在转化的(L576P)KIT 黑素细胞中激活 cAMP 途径可刺激 MITF 表达,并减少细胞增殖和球体形成。这些发现强调了 MITF 在揭示 KIT 在黑素细胞中的致癌活性方面的重要作用,并表明 cAMP 途径是 KIT 突变黑素瘤的治疗靶点。

相似文献

1
Hypoxia and MITF regulate KIT oncogenic properties in melanocytes.缺氧和 MITF 调节黑素细胞中的 KIT 致癌特性。
Oncogene. 2016 Sep 22;35(38):5070-7. doi: 10.1038/onc.2016.39. Epub 2016 Mar 14.
2
c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes.c-Kit 突变体需要缺氧诱导因子 1α 来转化黑素细胞。
Oncogene. 2010 Jan 14;29(2):227-36. doi: 10.1038/onc.2009.320. Epub 2009 Oct 5.
3
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.达沙替尼通过激活携带突变或扩增 c-Kit 的黑色素瘤中的 CRTC3/MITF/Bcl-2 通路来刺激自身的耐药机制。
Mol Cancer Res. 2021 Jul;19(7):1221-1233. doi: 10.1158/1541-7786.MCR-20-1040. Epub 2021 Mar 19.
4
The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.AP-1转录因子FOSL1可导致黑素细胞重编程和转化。
Oncogene. 2017 Sep 7;36(36):5110-5121. doi: 10.1038/onc.2017.135. Epub 2017 May 8.
5
KIT Induces SRC-Mediated Tyrosine Phosphorylation of MITF and Altered Transcription Program in Melanoma.KIT 诱导 SRC 介导的 MITF 酪氨酸磷酸化和黑色素瘤中转录程序改变。
Mol Cancer Res. 2017 Sep;15(9):1265-1274. doi: 10.1158/1541-7786.MCR-17-0149. Epub 2017 Jun 5.
6
A single UVB exposure increases the expression of functional KIT in human melanocytes by up-regulating MITF expression through the phosphorylation of p38/CREB.单次 UVB 照射通过磷酸化 p38/CREB 上调 MITF 表达来增加人黑素细胞中功能性 KIT 的表达。
Arch Dermatol Res. 2010 May;302(4):283-94. doi: 10.1007/s00403-009-1007-x. Epub 2009 Nov 24.
7
Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.MITF的高表达可抵消B-RAF刺激的黑素细胞和黑素瘤细胞增殖。
J Cell Biol. 2005 Aug 29;170(5):703-8. doi: 10.1083/jcb.200505059.
8
MITF pathway mutations in melanoma.黑色素瘤中的MITF通路突变。
Pigment Cell Melanoma Res. 2009 Aug;22(4):376-7. doi: 10.1111/j.1755-148X.2009.00599.x. Epub 2009 Jun 25.
9
C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation.C-KIT 信号依赖小眼畸形相关转录因子发挥对细胞增殖的影响。
PLoS One. 2011;6(8):e24064. doi: 10.1371/journal.pone.0024064. Epub 2011 Aug 24.
10
[The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].[MITF信号通路在恶性黑色素瘤增殖和侵袭调控中的重要性]
Klin Onkol. 2016 Fall;29(5):347-350. doi: 10.14735/amko2016347.

引用本文的文献

1
Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growth.小眼畸形相关转录因子抑制剂ML329对胃肠道间质瘤生长影响的临床前研究
Mol Ther Oncol. 2025 Apr 14;33(2):200983. doi: 10.1016/j.omton.2025.200983. eCollection 2025 Jun 18.
2
Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance.肿瘤微环境诱导的肿瘤细胞可塑性:与缺氧应激的关系及其对肿瘤耐药性的影响。
Front Oncol. 2023 Oct 11;13:1222575. doi: 10.3389/fonc.2023.1222575. eCollection 2023.
3
Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance.

本文引用的文献

1
Driver KIT mutations in melanoma cluster in four hotspots.黑色素瘤中的驱动基因KIT突变集中在四个热点区域。
Melanoma Res. 2015 Feb;25(1):88-90. doi: 10.1097/CMR.0000000000000116.
2
Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.衰老黑素瘤的分泌蛋白组激活信号转导和转录激活因子3(STAT3)通路,促使幼稚黑素瘤重编程为肿瘤起始细胞表型。
Oncotarget. 2013 Dec;4(12):2212-24. doi: 10.18632/oncotarget.1143.
3
Targeting activated KIT signaling for melanoma therapy.
缺氧和细胞外酸化作为推动黑色素瘤进展和耐药的因素。
Cells. 2021 Apr 9;10(4):862. doi: 10.3390/cells10040862.
4
Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.根据亚型分析黑素瘤中 KIT 基因突变的分布和临床作用:西班牙 492 例患者研究。
Eur J Dermatol. 2021 Dec 1;31(6):830-838. doi: 10.1684/ejd.2021.3971.
5
Critical role of glioma-associated oncogene homolog 1 in maintaining invasive and mesenchymal-like properties of melanoma cells.胶质瘤相关癌基因同源物1在维持黑色素瘤细胞侵袭性和间充质样特性中的关键作用。
Cancer Sci. 2017 Aug;108(8):1602-1611. doi: 10.1111/cas.13294. Epub 2017 Jul 11.
靶向激活的KIT信号通路用于黑色素瘤治疗。
J Clin Oncol. 2013 Sep 10;31(26):3288-90. doi: 10.1200/JCO.2013.50.3227. Epub 2013 Aug 12.
4
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.伊马替尼治疗黏膜、肢端和慢性日光损伤皮肤来源的突变或扩增 KIT 驱动的黑色素瘤。
J Clin Oncol. 2013 Sep 10;31(26):3182-90. doi: 10.1200/JCO.2012.47.7836. Epub 2013 Jun 17.
5
The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma.MAPK 通路作为冗余的存活信号,在 c-Kit 突变黑色素瘤中增强了 PI3K 级联反应。
Oncogene. 2014 Jan 9;33(2):236-45. doi: 10.1038/onc.2012.562. Epub 2012 Dec 17.
6
Genetic variation at KIT locus may predispose to melanoma.KIT 基因座的遗传变异可能易患黑色素瘤。
Pigment Cell Melanoma Res. 2013 Jan;26(1):88-96. doi: 10.1111/pcmr.12032. Epub 2012 Nov 23.
7
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines.研究性选择性 MEK 抑制剂 TAK733 对皮肤和葡萄膜黑色素瘤细胞系的抗肿瘤作用。
Mol Cancer. 2012 Apr 19;11:22. doi: 10.1186/1476-4598-11-22.
8
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.通过 Oct4 介导的去分化获得癌症干细胞表型。
Oncogene. 2012 Nov 22;31(47):4898-911. doi: 10.1038/onc.2011.656. Epub 2012 Jan 30.
9
Lack of correlation between immunohistochemical expression of CKIT and KIT mutations in atypical acral nevi.非典型肢端痣中CKIT免疫组化表达与KIT突变之间缺乏相关性。
Am J Dermatopathol. 2012 Feb;34(1):41-6. doi: 10.1097/DAD.0b013e31821ec0ef.
10
Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.缺氧和 MITF 控制小鼠和人黑色素瘤细胞的转移行为。
Oncogene. 2012 May 10;31(19):2461-70. doi: 10.1038/onc.2011.425. Epub 2011 Sep 26.